Integrating T cell metabolism in cancer immunotherapy
Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiatio...
Gespeichert in:
Veröffentlicht in: | Cancer letters 2017-12, Vol.411, p.12-18 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 18 |
---|---|
container_issue | |
container_start_page | 12 |
container_title | Cancer letters |
container_volume | 411 |
creator | Dugnani, Erica Pasquale, Valentina Bordignon, Carlotta Canu, Adriana Piemonti, Lorenzo Monti, Paolo |
description | Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiation into different cell subsets, effector function and development of long-lasting memory. This provides an opportunity to improve the T cell response through manipulation of metabolism, which is instrumental to ameliorate the current protocols for cancer immunotherapy. Using drugs and molecules targeting selective metabolic pathways it is now possible to generate T cells that can mount a durable and stable anti-tumor response. On the other hand, cancer cells can take advantage of the metabolic requirements of T cells to evade the immune response. In this brief review we discuss recent findings of T cell metabolism in quiescence and activation, how the tumor microenvironment can affect T cell metabolism, and how T cell metabolism can be manipulated to improve the T cell response to tumors.
•T cell activation, function and persistence depends on metabolic fitness.•T cell metabolism can be targeted to improve anti-tumor T cell response.•T cells using mitochondrial oxidative metabolism have improved anti-tumor activity.•The tumor microenvironement impairs T cell metabolic fitness. |
doi_str_mv | 10.1016/j.canlet.2017.09.039 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1947096910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383517306006</els_id><sourcerecordid>1947096910</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-6c99102964281e60dc75302c7f5980882dbff5010d0db8205e701055fb0286ad3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo7vrxD0QKXry0TtKkSS6CLH4sCF70HNp0qln6sSatsP_eLLt68OBpGHhm3peHkAsKGQVa3KwyW_YtjhkDKjPQGeT6gMypkiyVWsEhmUMOPM1VLmbkJIQVAAguxTGZMaUl51zNiVj2I777cnT9e_KaWGzbpMOxrIbWhS5xfRJTLPrEdd3UD-MH-nK9OSNHTdkGPN_PU_L2cP-6eEqfXx6Xi7vn1OYaxrSwWlNguuBMUSygtlLkwKxsRCyoFKurphFAoYa6UgwEyrgI0VTAVFHW-Sm53v1d--FzwjCazoVtx7LHYQqGai5BFzEkold_0NUw-T62i1QheF5QxiLFd5T1QwgeG7P2riv9xlAwW61mZXZazVarAW2i1nh2uX8-VR3Wv0c_HiNwuwMw2vhy6E2wDqO42nm0o6kH93_CN4zziAI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1965436122</pqid></control><display><type>article</type><title>Integrating T cell metabolism in cancer immunotherapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Dugnani, Erica ; Pasquale, Valentina ; Bordignon, Carlotta ; Canu, Adriana ; Piemonti, Lorenzo ; Monti, Paolo</creator><creatorcontrib>Dugnani, Erica ; Pasquale, Valentina ; Bordignon, Carlotta ; Canu, Adriana ; Piemonti, Lorenzo ; Monti, Paolo</creatorcontrib><description>Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiation into different cell subsets, effector function and development of long-lasting memory. This provides an opportunity to improve the T cell response through manipulation of metabolism, which is instrumental to ameliorate the current protocols for cancer immunotherapy. Using drugs and molecules targeting selective metabolic pathways it is now possible to generate T cells that can mount a durable and stable anti-tumor response. On the other hand, cancer cells can take advantage of the metabolic requirements of T cells to evade the immune response. In this brief review we discuss recent findings of T cell metabolism in quiescence and activation, how the tumor microenvironment can affect T cell metabolism, and how T cell metabolism can be manipulated to improve the T cell response to tumors.
•T cell activation, function and persistence depends on metabolic fitness.•T cell metabolism can be targeted to improve anti-tumor T cell response.•T cells using mitochondrial oxidative metabolism have improved anti-tumor activity.•The tumor microenvironement impairs T cell metabolic fitness.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2017.09.039</identifier><identifier>PMID: 28974448</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Animals ; Antigens ; Biosynthesis ; Cancer ; Cancer immunotherapy ; Cell activation ; Cell Differentiation - immunology ; Cell growth ; Cell survival ; Cytokines ; Drug delivery ; Energy ; Fatty acids ; Glycerol ; Humans ; Immune response ; Immuno-metabolism ; Immunosuppressive agents ; Immunotherapy ; Immunotherapy - methods ; Long term memory ; Lymphocyte Activation ; Lymphocytes ; Lymphocytes T ; Metabolic pathways ; Metabolism ; Metabolites ; Neoplasms - immunology ; Neoplasms - metabolism ; Neoplasms - therapy ; Phosphorylation ; Substrates ; T cell receptors ; T cells ; T-Lymphocytes - immunology ; T-Lymphocytes - metabolism ; Tumors</subject><ispartof>Cancer letters, 2017-12, Vol.411, p.12-18</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 28, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-6c99102964281e60dc75302c7f5980882dbff5010d0db8205e701055fb0286ad3</citedby><cites>FETCH-LOGICAL-c390t-6c99102964281e60dc75302c7f5980882dbff5010d0db8205e701055fb0286ad3</cites><orcidid>0000-0002-4452-2164</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.canlet.2017.09.039$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28974448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dugnani, Erica</creatorcontrib><creatorcontrib>Pasquale, Valentina</creatorcontrib><creatorcontrib>Bordignon, Carlotta</creatorcontrib><creatorcontrib>Canu, Adriana</creatorcontrib><creatorcontrib>Piemonti, Lorenzo</creatorcontrib><creatorcontrib>Monti, Paolo</creatorcontrib><title>Integrating T cell metabolism in cancer immunotherapy</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiation into different cell subsets, effector function and development of long-lasting memory. This provides an opportunity to improve the T cell response through manipulation of metabolism, which is instrumental to ameliorate the current protocols for cancer immunotherapy. Using drugs and molecules targeting selective metabolic pathways it is now possible to generate T cells that can mount a durable and stable anti-tumor response. On the other hand, cancer cells can take advantage of the metabolic requirements of T cells to evade the immune response. In this brief review we discuss recent findings of T cell metabolism in quiescence and activation, how the tumor microenvironment can affect T cell metabolism, and how T cell metabolism can be manipulated to improve the T cell response to tumors.
•T cell activation, function and persistence depends on metabolic fitness.•T cell metabolism can be targeted to improve anti-tumor T cell response.•T cells using mitochondrial oxidative metabolism have improved anti-tumor activity.•The tumor microenvironement impairs T cell metabolic fitness.</description><subject>Animals</subject><subject>Antigens</subject><subject>Biosynthesis</subject><subject>Cancer</subject><subject>Cancer immunotherapy</subject><subject>Cell activation</subject><subject>Cell Differentiation - immunology</subject><subject>Cell growth</subject><subject>Cell survival</subject><subject>Cytokines</subject><subject>Drug delivery</subject><subject>Energy</subject><subject>Fatty acids</subject><subject>Glycerol</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immuno-metabolism</subject><subject>Immunosuppressive agents</subject><subject>Immunotherapy</subject><subject>Immunotherapy - methods</subject><subject>Long term memory</subject><subject>Lymphocyte Activation</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Metabolic pathways</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - therapy</subject><subject>Phosphorylation</subject><subject>Substrates</subject><subject>T cell receptors</subject><subject>T cells</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - metabolism</subject><subject>Tumors</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo7vrxD0QKXry0TtKkSS6CLH4sCF70HNp0qln6sSatsP_eLLt68OBpGHhm3peHkAsKGQVa3KwyW_YtjhkDKjPQGeT6gMypkiyVWsEhmUMOPM1VLmbkJIQVAAguxTGZMaUl51zNiVj2I777cnT9e_KaWGzbpMOxrIbWhS5xfRJTLPrEdd3UD-MH-nK9OSNHTdkGPN_PU_L2cP-6eEqfXx6Xi7vn1OYaxrSwWlNguuBMUSygtlLkwKxsRCyoFKurphFAoYa6UgwEyrgI0VTAVFHW-Sm53v1d--FzwjCazoVtx7LHYQqGai5BFzEkold_0NUw-T62i1QheF5QxiLFd5T1QwgeG7P2riv9xlAwW61mZXZazVarAW2i1nh2uX8-VR3Wv0c_HiNwuwMw2vhy6E2wDqO42nm0o6kH93_CN4zziAI</recordid><startdate>20171228</startdate><enddate>20171228</enddate><creator>Dugnani, Erica</creator><creator>Pasquale, Valentina</creator><creator>Bordignon, Carlotta</creator><creator>Canu, Adriana</creator><creator>Piemonti, Lorenzo</creator><creator>Monti, Paolo</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4452-2164</orcidid></search><sort><creationdate>20171228</creationdate><title>Integrating T cell metabolism in cancer immunotherapy</title><author>Dugnani, Erica ; Pasquale, Valentina ; Bordignon, Carlotta ; Canu, Adriana ; Piemonti, Lorenzo ; Monti, Paolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-6c99102964281e60dc75302c7f5980882dbff5010d0db8205e701055fb0286ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Antigens</topic><topic>Biosynthesis</topic><topic>Cancer</topic><topic>Cancer immunotherapy</topic><topic>Cell activation</topic><topic>Cell Differentiation - immunology</topic><topic>Cell growth</topic><topic>Cell survival</topic><topic>Cytokines</topic><topic>Drug delivery</topic><topic>Energy</topic><topic>Fatty acids</topic><topic>Glycerol</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immuno-metabolism</topic><topic>Immunosuppressive agents</topic><topic>Immunotherapy</topic><topic>Immunotherapy - methods</topic><topic>Long term memory</topic><topic>Lymphocyte Activation</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Metabolic pathways</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - therapy</topic><topic>Phosphorylation</topic><topic>Substrates</topic><topic>T cell receptors</topic><topic>T cells</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dugnani, Erica</creatorcontrib><creatorcontrib>Pasquale, Valentina</creatorcontrib><creatorcontrib>Bordignon, Carlotta</creatorcontrib><creatorcontrib>Canu, Adriana</creatorcontrib><creatorcontrib>Piemonti, Lorenzo</creatorcontrib><creatorcontrib>Monti, Paolo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dugnani, Erica</au><au>Pasquale, Valentina</au><au>Bordignon, Carlotta</au><au>Canu, Adriana</au><au>Piemonti, Lorenzo</au><au>Monti, Paolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrating T cell metabolism in cancer immunotherapy</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2017-12-28</date><risdate>2017</risdate><volume>411</volume><spage>12</spage><epage>18</epage><pages>12-18</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiation into different cell subsets, effector function and development of long-lasting memory. This provides an opportunity to improve the T cell response through manipulation of metabolism, which is instrumental to ameliorate the current protocols for cancer immunotherapy. Using drugs and molecules targeting selective metabolic pathways it is now possible to generate T cells that can mount a durable and stable anti-tumor response. On the other hand, cancer cells can take advantage of the metabolic requirements of T cells to evade the immune response. In this brief review we discuss recent findings of T cell metabolism in quiescence and activation, how the tumor microenvironment can affect T cell metabolism, and how T cell metabolism can be manipulated to improve the T cell response to tumors.
•T cell activation, function and persistence depends on metabolic fitness.•T cell metabolism can be targeted to improve anti-tumor T cell response.•T cells using mitochondrial oxidative metabolism have improved anti-tumor activity.•The tumor microenvironement impairs T cell metabolic fitness.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>28974448</pmid><doi>10.1016/j.canlet.2017.09.039</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-4452-2164</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-3835 |
ispartof | Cancer letters, 2017-12, Vol.411, p.12-18 |
issn | 0304-3835 1872-7980 |
language | eng |
recordid | cdi_proquest_miscellaneous_1947096910 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Animals Antigens Biosynthesis Cancer Cancer immunotherapy Cell activation Cell Differentiation - immunology Cell growth Cell survival Cytokines Drug delivery Energy Fatty acids Glycerol Humans Immune response Immuno-metabolism Immunosuppressive agents Immunotherapy Immunotherapy - methods Long term memory Lymphocyte Activation Lymphocytes Lymphocytes T Metabolic pathways Metabolism Metabolites Neoplasms - immunology Neoplasms - metabolism Neoplasms - therapy Phosphorylation Substrates T cell receptors T cells T-Lymphocytes - immunology T-Lymphocytes - metabolism Tumors |
title | Integrating T cell metabolism in cancer immunotherapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T20%3A59%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrating%20T%20cell%20metabolism%20in%20cancer%20immunotherapy&rft.jtitle=Cancer%20letters&rft.au=Dugnani,%20Erica&rft.date=2017-12-28&rft.volume=411&rft.spage=12&rft.epage=18&rft.pages=12-18&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2017.09.039&rft_dat=%3Cproquest_cross%3E1947096910%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1965436122&rft_id=info:pmid/28974448&rft_els_id=S0304383517306006&rfr_iscdi=true |